3,4-dihydroxybenzohydroxamic acid has been researched along with Hemolysis in 1 studies
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, JAF | 1 |
| Gotardo, ÉMF | 1 |
| Chweih, H | 1 |
| Miguel, LI | 1 |
| Ferreira, WA | 1 |
| Hedlund, B | 1 |
| Elford, HL | 1 |
| Leonardo, FC | 1 |
| Costa, FF | 1 |
| Conran, N | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Hemolysis
| Article | Year |
|---|---|
Didox (3,4-dihydroxybenzohydroxamic acid) reduces the vascular inflammation induced by acute intravascular hemolysis.
Topics: Blood Vessels; Hemolysis; Humans; Hydroxamic Acids; Inflammation | 2020 |